Suzetrigine in Equestrian Sports: Optimized Extraction and LC-HRMS Detection Strategies

Rationale: Suzetrigine, a recently approved Na V1.8 sodium channel blocker, shows strong potential in the treatment of neurological, psychiatric, and pain-related conditions. Its peripheral selectivity enables effective pain management while avoiding